Search for: "Teikoku Seiyaku Co Ltd" Results 1 - 2 of 2
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Aug 2012, 10:01 am by James McArdle
Patent 5,827,529 (referred to as “529 Patent) by Noven Therapeutics/Noven Pharmaceuticals, makers of products such as the ADHD drug Daytrana, at a considerable harm to the transdermal drug delivery technology company Teikoku Seiyaku, Co., Ltd., holders of the patent, and Endo Pharmaceuticals, manufacturers of a 5% lidocaine patch that relieves pain associated with post-herpetic neuralgia utilizing technology covered by the patent. [read post]
18 Apr 2016, 12:49 pm by Gene Quinn
Simultaneously with the filing of the complaint, the Commission also filed a stipulated order for permanent injunction against Teikoku Seiyaku Co., Ltd. and Teikoku Pharma USA, Inc., settling charges for those two defendants. [read post]